Click
here for CIT NUSLive webcast!
Presentation materials for the talk:
Presentation Slides
Title :
|
"Biotechnology business today - building a sustainable passion ? " |
|
Speaker : |
Mr. Steven Fang, Group CEO for Cordlife, Cytomatrix and Cell Sciences ; Chairman of BioSingapore |
|
Date: |
7 July 2005 (Thursday) |
|
Time: |
6.00pm - 7.30 pm (Registration starts at 5.30pm) |
Seminars organised by
the Entrepreneurship
Centre are now on the
CIT NUSLive website |
Venue: |
LT 18, NUS Business School(http://www.nus.edu.sg/campusmap/)
Pls click on "NUS Business School" on the campus map to to locate the LT. |
Driving and Parking: |
Enter Kent Ridge Drive by Pasir Panjang Road or Kent Ridge Crescent. The nearest car park is just next to Hon Sui Sen Auditorium. The next nearest car parks are next to Institute of Materials Research & Engineering and NUSS Guild House. |
Abstract
- The market evolution of biotechnology
- Past successful models
- Current market challenges
- Current model trends
- About fund raising and assessing risk capital
- About IP
- About people and management
- Going global
- What shareholders seek?
- IPO vs. trade sales
- Building a sustainable passion
About the Speaker
Mr. Fang is intimately familiar with the healthcare and Biotechnology business, with over 18 years of management and operational business development experiences in Asia Pacific and USA. He has previously worked for Sterling Withthrop Pharmaceutical, Baxter Inc and Becton Dickinson Inc, having undertaken various market development and management assignments in USA, China, Malaysia, Korea, Taiwan and the Philippines. While at Becton Dickinson, he was the General Manager for SEA. Mr. Fang has a first degree in Computer Engineering, an MBA with the University of Hull (U.K.) in Strategic Business Strategy in Business Globalization, and a post-graduate degree with INSEAD in M&A. Mr. Fang incorporated Cordlife in 2001 and has since taken this start-up to become an internationally recognised and ASX listed biotechnology company today with a market capitalisation exceeding A$60million. Mr. Fang is the Group CEO for Cordlife, Cytomatrix and Cell Sciences representing its three core Business Divisions in tissue banking, Cell theraphy, T-Cell production, Theranostic, Cell based assaying, Cell growth products and distribution.
Registration
We are pleased to invite you and your colleagues to attend the talk. As there is limited number of seats available please register for the talk by 7 July 2005 (noon). Please forward this invitation to your friends and colleagues who may be interested. Thank You!
Admission is FREE & we look forward to seeing you at the seminar.
